Among stroke survivors, poor sleep quality is prevalent and influenced by stroke location, type, and the country’s income level.

Dr. Marty Makary, head of the U.S. Food and Drug Administration (FDA), said Wednesday that the decision should be made between a pregnant woman and her doctor. “The data on the COVID vaccine booster ...

Patients with diabetic kidney disease (DKD) and anemia have no worse, and possibly better, cardiovascular outcomes from finerenone treatment.

Statins recommended for persons with HIV with a 10-year ASCVD risk score of 5% or higher; favored for those with risk score <5%.

Sepsis-associated CVD mortality increased in the United States after the start of the COVID-19 pandemic, with the highest rates observed in older adults and Black patients.

Hypoxemia went undetected in 0.8% of critically ill Asian patients when oxygen saturation was measured via pulse oximetry (SpO2) vs SaO2.

Dr Joshua D Safer and Dr C Streed Jr discuss the importance of cardiovascular care among transgender and gender-diverse ...

Post hoc results support the initiation of SGLT2 inhibitors in patients with diabetic nephropathy regardless of iron deficiency. Canagliflozin treatment may improve iron markers and hemoglobin levels ...

There are similarities and differences in the sources of sodium and sodium reduction behaviors between racial and ethnic groups.

SGLT-2 inhibitor use vs DPP-4 inhibitor use was associated with lower incidence of epilepsy among patients with type 2 diabetes.

As of mid-May, this variant has been identified in nearly 11 percent of sequenced samples reported worldwide. The WHO has designated this variant as a “variant under monitoring,” and currently ...

A scientific statement has been published by the AHA regarding palliative and end-of-life care in patients with critical cardiovascular illness.